fenofibrate has been researched along with Cholelithiasis in 4 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Cholelithiasis: Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fibrates are widely used for treatment of hyperlipidemia." | 1.32 | A patient with hyperlipidemia who had a gallbladder stone caused by administration of fenofibrate. ( Egashira, T; Inuzuka, S; Kinoshita, J; Kumamoto, M; Sata, M; Shishido, S; Tomiyasu, N; Ueno, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roglans, N | 1 |
| Bellido, A | 1 |
| Rodríguez, C | 1 |
| Cabrero, A | 1 |
| Novell, F | 1 |
| Ros, E | 1 |
| Zambón, D | 1 |
| Laguna, JC | 1 |
| Inuzuka, S | 1 |
| Tomiyasu, N | 1 |
| Kumamoto, M | 1 |
| Egashira, T | 1 |
| Kinoshita, J | 1 |
| Shishido, S | 1 |
| Sata, M | 1 |
| Ueno, T | 1 |
| Caroli-Bosc, FX | 1 |
| Le Gall, P | 1 |
| Pugliese, P | 1 |
| Delabre, B | 1 |
| Caroli-Bosc, C | 1 |
| Demarquay, JF | 1 |
| Delmont, JP | 1 |
| Rampal, P | 1 |
| Montet, JC | 1 |
| Podda, M | 1 |
| Zuin, M | 1 |
1 trial available for fenofibrate and Cholelithiasis
| Article | Year |
|---|---|
Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver.
Topics: Acyl-CoA Oxidase; Apolipoprotein A-I; Apolipoproteins B; Bezafibrate; Carnitine O-Palmitoyltransfera | 2002 |
3 other studies available for fenofibrate and Cholelithiasis
| Article | Year |
|---|---|
A patient with hyperlipidemia who had a gallbladder stone caused by administration of fenofibrate.
Topics: Cholelithiasis; Female; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Middle Aged; Tom | 2003 |
Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population.
Topics: Anticholesteremic Agents; Cholelithiasis; Double-Blind Method; Female; Fenofibrate; Humans; Hydroxym | 2001 |
Effects of fenofibrate on biliary lipids and bile acid pool size in patients with type IV hyperlipoproteinemia.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Cholelithiasis; Cholesterol; Female; Fenofibrate; Humans; H | 1985 |